Indinavir
From Proteopedia
(Difference between revisions)
| Line 21: | Line 21: | ||
! Saquinavir | ! Saquinavir | ||
! Amprenavir | ! Amprenavir | ||
| - | ! Foxamprenavir | ||
! Lopinavir | ! Lopinavir | ||
! Ritonavir | ! Ritonavir | ||
| Line 34: | Line 33: | ||
! Saquinavir | ! Saquinavir | ||
! Amprenavir | ! Amprenavir | ||
| - | ! Foxamprenavir | ||
! Lopinavir | ! Lopinavir | ||
! Ritonavir | ! Ritonavir | ||
| Line 47: | Line 45: | ||
! Saquinavir | ! Saquinavir | ||
! Amprenavir | ! Amprenavir | ||
| - | ! Foxamprenavir | ||
! Lopinavir | ! Lopinavir | ||
! Ritonavir | ! Ritonavir | ||
| Line 60: | Line 57: | ||
! Saquinavir | ! Saquinavir | ||
! Amprenavir | ! Amprenavir | ||
| - | ! Foxamprenavir | ||
! Lopinavir | ! Lopinavir | ||
! Ritonavir | ! Ritonavir | ||
| Line 73: | Line 69: | ||
! Saquinavir | ! Saquinavir | ||
! Amprenavir | ! Amprenavir | ||
| - | ! Foxamprenavir | ||
! Lopinavir | ! Lopinavir | ||
! Ritonavir | ! Ritonavir | ||
| Line 86: | Line 81: | ||
! Saquinavir | ! Saquinavir | ||
! Amprenavir | ! Amprenavir | ||
| - | ! Foxamprenavir | ||
! Lopinavir | ! Lopinavir | ||
! Ritonavir | ! Ritonavir | ||
| Line 99: | Line 93: | ||
! Saquinavir | ! Saquinavir | ||
! Amprenavir | ! Amprenavir | ||
| - | ! Foxamprenavir | ||
! Lopinavir | ! Lopinavir | ||
! Ritonavir | ! Ritonavir | ||
| Line 112: | Line 105: | ||
! Saquinavir | ! Saquinavir | ||
! Amprenavir | ! Amprenavir | ||
| - | ! Foxamprenavir | ||
! Lopinavir | ! Lopinavir | ||
! Ritonavir | ! Ritonavir | ||
| Line 125: | Line 117: | ||
! Saquinavir | ! Saquinavir | ||
! Amprenavir | ! Amprenavir | ||
| - | ! Foxamprenavir | ||
! Lopinavir | ! Lopinavir | ||
! Ritonavir | ! Ritonavir | ||
| Line 138: | Line 129: | ||
! Saquinavir | ! Saquinavir | ||
! Amprenavir | ! Amprenavir | ||
| - | ! Foxamprenavir | ||
! Lopinavir | ! Lopinavir | ||
! Ritonavir | ! Ritonavir | ||
Revision as of 18:51, 1 December 2010
|
Better Known as:
- Marketed By:
- Major Indication: Human Immunodeficiency Virus Infection
- Drug Class: HIV Protease Inhibitor
- Date of FDA Approval (Patent Expiration):
- 2006 Sales:
- Importance:
- The following is a list of Pharmacokinetic Parameters. See: Pharmaceutical Drugs for more information
Mechanism of Action
Pharmacokinetics
| HIV Protease Inhibitor Pharmacokinetics | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Parameter | Ritonavir | Tipranavir | Indinavir | Saquinavir | Amprenavir | Lopinavir | Ritonavir | Darunavir | Atazanavir | Nelfinavir | |
| Tmax (hr) | Ritonavir | Tipranavir | Indinavir | Saquinavir | Amprenavir | Lopinavir | Ritonavir | Darunavir | Atazanavir | Nelfinavir | |
| Cmax (ng/ml) | Ritonavir | Tipranavir | Indinavir | Saquinavir | Amprenavir | Lopinavir | Ritonavir | Darunavir | Atazanavir | Nelfinavir | |
| Bioavailability (%) | Ritonavir | Tipranavir | Indinavir | Saquinavir | Amprenavir | Lopinavir | Ritonavir | Darunavir | Atazanavir | Nelfinavir | |
| Protein Binding (%) | Ritonavir | Tipranavir | Indinavir | Saquinavir | Amprenavir | Lopinavir | Ritonavir | Darunavir | Atazanavir | Nelfinavir | |
| T1/2 (hr) | Ritonavir | Tipranavir | Indinavir | Saquinavir | Amprenavir | Lopinavir | Ritonavir | Darunavir | Atazanavir | Nelfinavir | |
| AUC (ng/ml/hr) | Ritonavir | Tipranavir | Indinavir | Saquinavir | Amprenavir | Lopinavir | Ritonavir | Darunavir | Atazanavir | Nelfinavir | |
| IC50 (nM) | Ritonavir | Tipranavir | Indinavir | Saquinavir | Amprenavir | Lopinavir | Ritonavir | Darunavir | Atazanavir | Nelfinavir | |
| Dosage (mg) | Ritonavir | Tipranavir | Indinavir | Saquinavir | Amprenavir | Lopinavir | Ritonavir | Darunavir | Atazanavir | Nelfinavir | |
| Metabolism | Ritonavir | Tipranavir | Indinavir | Saquinavir | Amprenavir | Lopinavir | Ritonavir | Darunavir | Atazanavir | Nelfinavir | |
References
